Prelude Therapeutics Incorporated (PRLD) Stock Price, Quote & AI Analysis
Live PRLD stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Prelude Therapeutics Incorporated.
TradeVae provides AI-driven analysis and real-time market intelligence for Prelude Therapeutics Incorporated (PRLD), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Prelude Therapeutics Incorporated's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Prelude Therapeutics Incorporated Overview
Company information
Company Overview
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Prelude Therapeutics Incorporated Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...